{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:11:31Z","timestamp":1763017891020,"version":"build-2065373602"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA214960-01A1","R21NR016736"],"award-info":[{"award-number":["1R01CA214960-01A1","R21NR016736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society Mentored Research Scholar","award":["MRSG-14-1418-01-CCE"],"award-info":[{"award-number":["MRSG-14-1418-01-CCE"]}]},{"name":"Andrew Sabin Family Fellowship Award"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.hoc.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T18:53:01Z","timestamp":1525287181000},"page":"387-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Safe Opioid Use"],"prefix":"10.1016","volume":"32","author":[{"given":"Joseph","family":"Arthur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s002280050200","article-title":"Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects","volume":"51","author":"Poulsen","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hoc.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0304-3959(95)00128-X","article-title":"Age is the best predictor of postoperative morphine requirements","volume":"64","author":"Macintyre","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1244::AID-CNCR26>3.0.CO;2-4","article-title":"Age, pain intensity, and opioid dose in patients with advanced cancer","volume":"83","author":"Vigano","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.01.003_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0885-3924(91)90961-3","article-title":"Chronic nausea and morphine-6-glucuronide","volume":"6","author":"Hagen","year":"1991","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.hoc.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.1993.127","article-title":"The pharmacokinetics of morphine and morphine glucuronides in kidney failure","volume":"54","author":"Osborne","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hoc.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1990.tb03638.x","article-title":"The metabolism and bioavailability of morphine in patients with severe liver cirrhosis","volume":"29","author":"Hasselstrom","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hoc.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.2000.18.8.1780","article-title":"Drug interactions in palliative care","volume":"18","author":"Bernard","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.01.003_bib8","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.hoc.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","article-title":"Side effects of opioids during short-term administration: effect of age, gender, and race","volume":"74","author":"Cepeda","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hoc.2018.01.003_bib11","first-page":"137","article-title":"Dopamine receptor antagonists","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","article-title":"Opioid induced nausea and vomiting","volume":"722","author":"Smith","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hoc.2018.01.003_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11894-017-0560-2","article-title":"Opioid-related constipation in patients with non-cancer pain syndromes: a review of evidence-based therapies and justification for a change in nomenclature","volume":"19","author":"Brenner","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.hoc.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","article-title":"Incidence, prevalence, and management of opioid bowel dysfunction","volume":"182","author":"Pappagallo","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.hoc.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpainsymman.2012.02.008","article-title":"Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients","volume":"45","author":"Tarumi","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.hoc.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain","volume":"322","author":"Allan","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.hoc.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/ajg.2013.169","article-title":"Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hoc.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib19","unstructured":"FDA approves methylnaltrexone bromide for oral use, 2016. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208271s000lbl.pdf. Accessed February 27, 2018."},{"key":"10.1016\/j.hoc.2018.01.003_bib20","unstructured":"NDA 21-775 ENTEREG (alvimopan) REMS October 6, 2008. Risk Evaluation and\u00a0Mitigation Strategy (REMS). Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021775s001REMS.pdf. Accessed February 27, 2018."},{"key":"10.1016\/j.hoc.2018.01.003_bib21","first-page":"231","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib22","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/cncr.10389","article-title":"The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal","volume":"94","author":"Lawlor","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(92)90053-E","article-title":"Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain","volume":"48","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1345\/aph.1E309","article-title":"Pharmacologic treatment of opioid-induced sedation in chronic pain","volume":"39","author":"Reissig","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hoc.2018.01.003_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0885-3924(00)00228-1","article-title":"Opioid poorly-responsive cancer pain. Part 1: clinical considerations","volume":"21","author":"Mercadante","year":"2001","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.hoc.2018.01.003_bib26","first-page":"70","article-title":"The management of cancer pain","volume":"50","author":"Cherny","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2018.01.003_bib27","first-page":"61","article-title":"Current management of opioid-related side effects","volume":"15","author":"O'Mahony","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.hoc.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF03011037","article-title":"Side effects of intrathecal and epidural opioids","volume":"42","author":"Chaney","year":"1995","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.hoc.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"894.e1-9","DOI":"10.1016\/j.ejpain.2010.03.003","article-title":"Analgesic efficacy and adverse effects of epidural morphine compared to parenteral opioids after elective caesarean section: a systematic review","volume":"14","author":"Bonnet","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","article-title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2018.01.003_bib31","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2165\/00003495-200767160-00003","article-title":"Pathophysiology and management of opioid-induced pruritus","volume":"67","author":"Ganesh","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.hoc.2018.01.003_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/AJP.0000000000000211","article-title":"Nalbuphine for treatment of opioid-induced pruritus: a systematic review of literature","volume":"32","author":"Jannuzzi","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2013misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02854840","article-title":"Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids","volume":"17","author":"Passik","year":"2000","journal-title":"Adv Ther"},{"first-page":"19","year":"1996","series-title":"World Health Organization. Cancer pain relief with a guide to opioid availability","key":"10.1016\/j.hoc.2018.01.003_bib35"},{"key":"10.1016\/j.hoc.2018.01.003_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1983.03330300035030","article-title":"The prevalence of psychiatric disorders among cancer patients","volume":"249","author":"Derogatis","year":"1983","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.hoc.2018.01.003_bib37","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2018.01.003_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1634\/theoncologist.2015-0012","article-title":"Frequency, predictors, and medical record documentation of chemical coping among advanced cancer patients","volume":"20","author":"Kwon","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.hoc.2018.01.003_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11916-010-0118-6","article-title":"Substance abuse in cancer pain","volume":"14","author":"Starr","year":"2010","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.hoc.2018.01.003_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AJP.0b013e3180330dc5","article-title":"Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain","volume":"23","author":"Wasan","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.hoc.2018.01.003_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/theoncologist.2016-0266","article-title":"The impact of an educational program on patient practices for safe use, storage, and disposal of opioids at a comprehensive cancer center","volume":"22","author":"de la Cruz","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.hoc.2018.01.003_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.20452\/pamw.741","article-title":"2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?","volume":"119","author":"Chou","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.hoc.2018.01.003_bib44","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1002\/cncr.30240","article-title":"Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic","volume":"122","author":"Arthur","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.01.003_bib45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.6004\/jnccn.2013.0120","article-title":"Opioid misuse and abuse: risk assessment and management in patients with cancer pain","volume":"11","author":"Anghelescu","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.hoc.2018.01.003_bib46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1526-4637.2009.00743.x","article-title":"A\u00a0comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management","volume":"10","author":"Moore","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/occmed\/kqu058","article-title":"The CAGE questionnaire","volume":"64","author":"Williams","year":"2014","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.hoc.2018.01.003_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(82)91579-3","article-title":"Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism","volume":"1","author":"Bernadt","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2018.01.003_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1300\/J069v17n02_05","article-title":"Efficiency and validity of commonly used substance abuse screening instruments in public psychiatric patients","volume":"17","author":"Dyson","year":"1998","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.hoc.2018.01.003_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pain.2004.07.026","article-title":"Validation of a screener and opioid assessment measure for patients with chronic pain","volume":"112","author":"Butler","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib52","first-page":"1883","article-title":"Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen","volume":"22","author":"Barclay","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.hoc.2018.01.003_bib53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/AJP.0b013e3181f195ba","article-title":"Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy","volume":"26","author":"Butler","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2006.05.010","article-title":"The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain","volume":"32","author":"Wu","year":"2006","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.hoc.2018.01.003_bib55","first-page":"507","article-title":"The influence of prescription monitoring programs on chronic pain management","volume":"12","author":"Wang","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.hoc.2018.01.003_bib56","unstructured":"Prescription drug monitoring program training and technical assistance center. Available at: http:\/\/www.pdmpassist.org\/content\/state-pdmp-websites. Accessed February 27, 2018."},{"key":"10.1016\/j.hoc.2018.01.003_bib57","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1526-4637.2012.01412.x","article-title":"Influencing controlled substance prescribing: attending and resident physician use of a state prescription monitoring program","volume":"13","author":"Feldman","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cll.2012.07.001","article-title":"Urine drug testing for pain management","volume":"32","author":"Magnani","year":"2012","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib59","unstructured":"Lock it up: medicine safety in your home. US Food and Drug Administration Web site. Available at: www.fda.gov\/forconsumers\/consumerupdates\/ucm272905.htm. Accessed February 27, 2018."},{"key":"10.1016\/j.hoc.2018.01.003_bib60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib61","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/archpsyc.1985.01790340045007","article-title":"DSM-III psychiatric diagnosis of narcotic addicts. Recent findings","volume":"42","author":"Khantzian","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.hoc.2018.01.003_bib62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pain.2010.02.033","article-title":"Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial","volume":"150","author":"Jamison","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2018.01.003_bib63","first-page":"517","article-title":"Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis","volume":"12","author":"Passik","year":"1998","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"10.1016\/j.hoc.2018.01.003_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.2017-0248","article-title":"Outcomes of a specialized interdisciplinary approach for patients with cancer with aberrant opioid-related behavior","volume":"23","author":"Arthur","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.hoc.2018.01.003_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"NOnrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/jpm.2014.0446","article-title":"A\u00a0pilot study to define chemical coping in cancer patients using the Delphi method","volume":"18","author":"Kwon","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.hoc.2018.01.003_bib67","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.2013.52.5170","article-title":"Assessment and management of chemical coping in patients with cancer","volume":"32","author":"Del Fabbro","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.01.003_bib68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.1988.03720040047025","article-title":"Clarification and standardization of substance abuse terminology","volume":"259","author":"Rinaldi","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2018.01.003_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","article-title":"Opioid pseudoaddiction\u2013an iatrogenic syndrome","volume":"36","author":"Weissman","year":"1989","journal-title":"Pain"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:05:19Z","timestamp":1760184319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889858818300133"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.01.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe Opioid Use","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}